MIXiii-Biomed Israel 2019 Conference and Exhibition
  • Home
  • Conference
    • Welcome Letter
    • Committees
    • Meet the Speakers of 2019
    • Program
      • Day 1
      • Day 2
      • Day 3
    • Instructions for Oral Presentations
    • Call for Company Presentations
    • Past Events
  • Exhibition
    • Start-up Area – List of Exhibitors
    • How to Exhibit
    • Information for Exhibitors
    • Sponsors & Exhibitors List
    • Digital Catalogue 2019
  • Sponsorship
  • Registration
  • Accommodations
    • Hotel Accommodations
    • Accommodation Reservation
  • Business Forum
    • Networking
  • Social
    • Satellite Events
    • Publications
    • Social Networks & PR Services
    • Media Partners
  • General
    • About Us
    • About Tel-Aviv
    • FAQ
    • Biomed 2018 by the Numbers
    • Gallery
    • Tours for Visitors
    • Privacy Policy
  • Contact
  • Home
  • Conference
    • Welcome Letter
    • Committees
    • Meet the Speakers of 2019
    • Program
      • Day 1
      • Day 2
      • Day 3
    • Instructions for Oral Presentations
    • Call for Company Presentations
    • Past Events
  • Exhibition
    • Start-up Area – List of Exhibitors
    • How to Exhibit
    • Information for Exhibitors
    • Sponsors & Exhibitors List
    • Digital Catalogue 2019
  • Sponsorship
  • Registration
  • Accommodations
    • Hotel Accommodations
    • Accommodation Reservation
  • Business Forum
    • Networking
  • Social
    • Satellite Events
    • Publications
    • Social Networks & PR Services
    • Media Partners
  • General
    • About Us
    • About Tel-Aviv
    • FAQ
    • Biomed 2018 by the Numbers
    • Gallery
    • Tours for Visitors
    • Privacy Policy
  • Contact

OurCrowd Invests $2.5 Million in Scopio Labs, Brings Total to $80 Million Invested in Healthcare Companies

  • admin
  • May 30, 2017
  • Blog

  OurCrowd, a global leader in equity crowdfunding, today announced that it will invest $2.5 million (as part of a recently completed $7 million investment round) in Scopio Labs, a…

Continue Reading

New technology can predict resistance to chemotherapy

  • admin
  • May 30, 2017
  • Blog

Breakthrough diagnostic kit under development can predict if a tumor will develop resistance to drugs, making therapy ineffective. By ISRAEL21c Staff MAY 24, 2017, 7:00 AM NewStem, a startup based…

Continue Reading

Israel and Quebec launch $12m R&D program

  • admin
  • May 30, 2017
  • Blog

  Setting up the collaboration program was one of the highlights of a week-long visit by a 100-strong trade delegation to Israel led by Quebec Premier Philippe Couillard. Israel and…

Continue Reading

Covington Invitation: Navigating Digital Health Risks and Opportunities in the U.S.

  • admin
  • May 24, 2017
  • Blog

  Premiere Biomed Event – Covington Satellite Event     16th MIXiii-BIOMED 2017 Conference and Exhibition – Satellite Symposium Navigating Digital Health Risks and Opportunities in the U.S. Dear Colleagues,…

Continue Reading

MEETING ELDERLY NEEDS

  • admin
  • May 23, 2017
  • Blog

Robotics, AI driving elderly med-tech market By Alfred Romann, Staff Writer                                      …

Continue Reading

Israeli robots and apps aim to make aging easier

  • admin
  • May 23, 2017
  • Blog / News

Israel is poised to lead the global boom in the digital health sector for the elderly, experts say BY SHOSHANNA SOLOMON May 22, 2017, 6:11 pm ‘Grow old along with…

Continue Reading

פיתוח ישראלי: בדיקה לאיתור מוקדם של אלצהיימר

  • admin
  • May 22, 2017
  • Blog / News

אפליקציה אבחונית חדשה תאתר סימנים מוקדמים למחלת האלצהיימר אצל מבוגרים בריאים בעזרת האינטרנט. "רק אם נוכל לאתר את החולים הפוטנציאליים נוכל לפתח תרופות שיגנו על המוח לפני שהוא ניזוק", אומר…

Continue Reading

העתיד כבר כאן: רובוטים יטפלו בקשישים

  • admin
  • May 22, 2017
  • Blog / News

 הזדקנות האוכלוסייה והצורך הגדל במטפלים מביא לפיתוח רובוטים חברתיים שיוכלו לסייע לקשישים לקיים אורח חיים עצמאי פורסם ב: 22.05.2017 09:30 עודכן ב: 22.05.2017 10:41 השמעת כתבה כאשר הטכנולוגיה כבר מגיעה…

Continue Reading

NeuroRx announces initiation of Israel-based Phase 3 research for treatment of Acute Suicidal Ideation and Behavior in Bipolar Depression

  • admin
  • May 22, 2017
  • Blog / News

  Tel Aviv, Israel – May 22, 2017 -- NeuroRx, a Gold Sponsor of the MIXiii, developing the first drug therapy for Acute Suicidal Ideation and Behavior (ASIB) in Bipolar…

Continue Reading

“טיפול נכון בזיקנה יאפשר לנו למות במצב גופני טוב יותר”

  • admin
  • May 21, 2017
  • Blog

יותר ויותר חוקרים מובילים בעולם מאמינים שניתן להתערב במנגנון ההתבגרות של הגוף ולמנוע את המחלות הנלוות לזיקנה ■ ראיון עם פרופ' ניר ברזילי וד"ר ולרי קריזנובסקי 21/05/2017, 07:31גלי וינרב "וודי…

Continue Reading
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 13

Recent Posts

  • To save the most precious – Life! (Russian)
  • 30 Israeli companies bring medtech innovations to North of England
  • The biomed market is flourishing, so how can the generics companies stay out of the party?
  • ‘Greatest emerging market’? Cannabis-based drug R&D finally going mainstream
  • The bio-tech industry has been identified as an economic growth in Israel

Archives

  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • November 2018
  • October 2018
  • September 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • August 2016

Categories

  • Blog
  • News
  • PR

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
Design and Develop: Navot Ram Web Solutions | All rights reserved to Kenes Exhibitions Inc. | SEO & Social Media, Ads by World Class Vision